Tisotumab ELISA Kit (GXEL00125)

(No reviews yet) Write a Review

SKU:
GXEL00125
Product Type:
ELISA Kit
Assay Type:
Quantitative
Detection Method:
Colorimetric
Sensitivity:
0.156 μg/ml
Range:
0.31-5 μg/mL
Size:
96T
Synonyms:
HuMax-TF-ADC, TF-011-MMAE, HuMax-TF, 1418628-81-5
€0.00
Frequently bought together:

Description

Tisotumab ELISA Kit

The Tisotumab ELISA Kit (SKU: GXEL00125) is a high-sensitivity quantitative ELISA assay developed for the quantitative measurement of Tisotumab in Plasma, Serum. The assay delivers a detection range of 0.31-5 μg/mL and a sensitivity of 0.156 μg/ml and is read colorimetrically at 450 nm, making it well suited to quantitative research workflows.

Tisotumab vedotin, also known as HuMax-TF, HuMax®-TF-ADC or TF-011-MMAE, is an antibody-drug conjugate (ADC) targeted to tissue factor (TF), a protein involved in tumor signaling and angiogenesis. Tisotumab vedotin includes an antibody targeting TF conjugated with monomethyl auristatin E (MMAE) via a cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Based on its high expression on many solid tumors (including ovarian, prostate, bladder, esophageal, endometrial and lung) and its rapid internalization, TF is considered a suitable target for antibody-drug conjugates. In pre-clinical trials tisotumab vedotin has shown strong ability to bind to TF and inhibit tumor growth. Genmab and Seattle Genetics are jointly developing tisotumab vedotin. In a Phase IIa study, preliminary data demonstrated a manageable safety profile and encouraging efficacy (ORR 37%) in relapsed, recurrent or metastatic cervical cancer.

Supplied with pre-coated microplates and all core reagents, the Tisotumab ELISA Kit gives you a validated, ready-to-use solution for Tisotumab research. Get accurate and reliable results with the Tisotumab ELISA Kit from Assay Genie.

View AllClose